Skip to main content
Sign In

You have reached the Web site for the Department of Pathology at the University of Colorado Denver.

The Graduate School at UC Denver

Cancer Biology Program Students

Hamid Gari

Why did you choose the UC Denver Cancer Biology Program?
Faculty research at UC Denver focuses on highly relevant, cutting-edge topics in translational cancer biology. Many of the projects on campus have real-world applicability, and this is evident by the number of faculty engaging with industry on discovery and development programs for various cancer indications. I was attracted to this caliber of academic research and enjoyed the prospect of directly interacting with an NCI-designated comprehensive cancer center on campus.
What labs are you rotating in?
Dan Theodorescu, M.D. Ph.D.
Stephen Malkoski, M.D. Ph.D.
Jim Lambert, Ph.D and Scott Lucia, M.D.
Please describe you project?
My doctoral thesis characterizes a novel oncogenic pathway and co-amplification paradigm that may mediate the malignancy of some invasive, triple negative breast cancers. If successful, my hope is that the thesis 1) will form foundational evidence and rationale for the therapeutic exploitation of this pathway in steroid-receptor negative breast cancer patients and 2) foster scientific appreciation for a new approach to killing cancer cells that takes advantage of highly evolved, dual-purpose cell regulation systems that become aberrant in cancer but yet, retain the ability to induce cellular senescence and/or apoptosis when manipulated pharmacologically.
Where did you attend undergraduate school and what was your major/minor?
Colorado State University: B.S. in Biomedical Sciences and Biochemistry
What you did (if anything) between undergraduate and graduate school?
I obtained my master’s degree in Bioscience Enterprise at the University of Cambridge, U.K. While there, and immediately following, I worked as a clinical development and late-stage marketing consultant to various Fortune 500 Pharma companies. My work often consisted of reverse-engineering oncology industry trends (from both macro-environmental health economic and clinical perspectives) to design competitive and relevant pivotal clinical trials, as well as broader clinical development program strategies in a given therapeutic area.
Other school affiliated activities/clubs you are involved in?
I often attend various clinically-oriented symposia and talks on campus that focus on current issues in the treatment of cancer. I think it provides additional context for the work often conducted in a research lab.
What do you like to do outside of school?
Spending time with friends, family, and travelling.
What is your favorite thing about Colorado?
The weather and nice people provide a great quality of life.
Your contact information-
office number: 303-724-7207